Solasia Pharma K.K.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • JapanBridge K.K.
  • Solasia Medical Information Consulting (Shanghai) Co. Ltd.
See more in Biomedtracker

Latest on Solasia Pharma K.K.

Scrip

Texas To Tokyo: Japan Darvias Approval Marks End Of Long Development Road

 
• By Lisa Takagi

Japanese bioventure Solasia Pharma K.K. 's Darvias (darinaparsin; SP-02) has received its first approval in Japan for the treatment of relapsed/refractory peripheral T-cell lymphoma (PTCL), marking t

Scrip

Deal Watch: RedHill Finds New Partner For Movantik

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. RedHill Sub-Licenses Some Rights To GI

Scrip

Asia Deal Watch: RAPT And Hanmi Partner On CCR4 Antagonist Offering Potential In Multiple Cancer Types

 
• By Jung Won Shin, Vibha Ravi, Joseph Haas, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . RAPT, Hanmi Ink Collaboratio

Scrip

Pipeline Watch: Top-line Phase III Results For KX2-391, Dasotraline And Brigatinib

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer